Ligand Pharmaceuticals News and Activities

Presence

Ligand Pharmaceuticals develops and licenses medicines and drug delivery technologies. Its products and services support pharmaceutical and biotechnology companies that need therapies, research tools, and development solutions.

Ligand Pharmaceuticals products and services overview:

Drug licensing
Drug delivery
Research tools
Biotech partnerships
Royalty assets

Revenue: ~$160 million

Employees: 70

Headquarters: San Diego, United States (USA)

Ligand Pharmaceuticals is one of the...

Ligand Pharmaceuticals is a company listed under the stock ticker LGND (US).

Ligand Pharmaceuticals has 3 subsidiaries including Captisol, Channel Therapeutics and Pelthos Therapeutics.

They are in:

Pharmaceuticals50%
Biotechnology50%

Acquisition, funding and merger involving Ligand Pharmaceuticals.

Xoma Royalty and Ligand Pharmaceuticals have announced they will merge (posted on April 27 2026)..

Executives

View the org chart displaying its 61 main executives

Most searched biographies at Ligand Pharmaceuticals

Popular executive movements at Ligand Pharmaceuticals

Peter Renehan has joined the company as Vice President, Investments and Business Development (posted on April 3 2026).
Lauren Hay who was Vice President, Strategic Planning and Investment Analytics, becomes Vice President of Portfolio Strategy and Investments (posted on April 3 2026).
Lee Brown has joined the company as Vice President, Investments & Business Development (posted on April 3 2026).

Create your alert
to follow the executive moves at Ligand Pharmaceuticals.